A Cross-Sectional Study to Evaluate Antimicrobial Susceptibility of Uropathogens from South Punjab, Pakistan

Background Urinary tract infections (UTIs) are a common infection caused by uropathogenic bacteria. Drug resistance against common antibiotics is a leading cause of treatment failure in UTIs. Objective This study was conducted to check the prevalence of antimicrobial susceptibility against uropathogens and identify the best treatment option against UTIs. Methods In this cross-sectional study, urine samples (n = 1000) were collected and cultured for pure bacterial growth by using cysteine–lactose–electrolyte-deficient (CLED) media. After physical and biochemical characterization, antibacterial susceptibility was performed by the Kirby–Bauer disk diffusion method. Results Uropathogenic bacteria were successfully isolated in 57% (n = 572) of total tested samples (n = 1000). Escherichia coli 51.2% (n = 293/572), Klebsiella species 15.4% (n = 88/572), Enterococcus species 15.4% (n = 88/572), Pseudomonas species 9.4% (n = 54/572), Staphylococcus aureus 3.2% (n = 18/572), coagulase-negative Staphylococci (CoNS) 3.0% (n = 17/572) and Proteus species 2.4% (n = 14/572) were the most prevalent organism in UTIs. Prevalence of Gram-negative rods (GNRs) was 78.5% (n = 449/572) among UTI patients as compared to Gram-positive cocci (GPCs) 21.5% (n = 123/572). Escherichia coli 65.3% (n = 293/449), Klebsiella species 19.6% (n = 88/449), Pseudomonas species 12.0% (54/449) and Proteus species 3.1% (n = 14/449) were the most prevalent GNRs in UTIs, while Enterococcus species 71.5% (n = 88/123), Staphylococcus aureus 14.6% (n = 18/123) and coagulase-negative Staphylococci (CoNS) 13.8% (17/123) were the most prevalent GPCs in UTIs. The majority of isolated uropathogens showed resistance against routinely used antibiotics. However, teicoplanin and linezolid were the most effective drugs against GPCs and piperacillin/tazobactam, meropenem and imipenem were the most effective drugs against GNRs. Nitrofurantoin and fosfomycin were shown to be most effective against both GNRs and GPCs. Conclusion In conclusion, Escherichia coli (GNRs) and Enterococcus species (GPCs) are the most prevalent organisms among UTIs patients, which are shown to be antibiotic-resistant to the most commonly used antibiotics. However, nitrofurantoin and fosfomycin are the most effective drugs against uropathogens in UTIs.

[1]  R. Humphries,et al.  Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition , 2021, Journal of clinical microbiology.

[2]  P. Behzadi,et al.  The prevalence of type 3 fimbriae in Uropathogenic Escherichia coli isolated from clinical urine samples , 2021 .

[3]  R. Ranjbar,et al.  Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae , 2021, Expert review of anti-infective therapy.

[4]  A. Sattar,et al.  Microbes and antibiotic susceptibility patterns of urinary tract infections in toilet-trained Children at a Tertiary Care Hospital of Sialkot, Pakistan. , 2021 .

[5]  H. García‐Perdomo,et al.  Metallo-ß-lactamases: a review , 2020, Molecular Biology Reports.

[6]  A. Palamara,et al.  FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens , 2020, Antibiotics.

[7]  E. Urbán,et al.  The Role of Gram-Negative Bacteria in Urinary Tract Infections: Current Concepts and Therapeutic Options. , 2020, Advances in experimental medicine and biology.

[8]  M. Rehman,et al.  Prevalence and antibiotic susceptibility pattern of uropathogens in outpatients at a tertiary care hospital , 2020, New microbes and new infections.

[9]  N. Javed,et al.  Microbial Resistance in Urinary Tract Infections , 2020, Cureus.

[10]  P. Behzadi,et al.  Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli , 2020, Journal of Applied Genetics.

[11]  M. Weinstein,et al.  The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes , 2020, Journal of Clinical Microbiology.

[12]  P. Behzadi.  Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs) , 2019, Folia Microbiologica.

[13]  P. Behzadi,et al.  Antimicrobial Agents and Urinary Tract Infections. , 2019, Current pharmaceutical design.

[14]  Melese Hailu Legese,et al.  Common uropathogens and their antibiotic susceptibility pattern among diabetic patients , 2019, BMC Infectious Diseases.

[15]  M. Anvarinejad,et al.  The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz , 2017, Medicine.

[16]  R. Sahoo,et al.  Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults , 2017, 3 Biotech.

[17]  Payam Behzadi,et al.  Uropathogenic Escherichia coli: An Ideal Resource for DNA Microarray Probe Designing , 2017, IWBBIO.

[18]  R. Gangane,et al.  Prevalence of MDR-ESBL producing Klebsiella pneumoniae isolated from clinical Samples. , 2017 .

[19]  R. Bharadwaj,et al.  Spectrum and Antimicrobial Susceptibility Pattern of Uropathogens: Indoor Versus Outdoor Isolates , 2017 .

[20]  Lisa K. McLellan,et al.  Urinary Tract Infection: Pathogenesis and Outlook. , 2016, Trends in molecular medicine.

[21]  T. Alnour,et al.  Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya. , 2016, Asian Pacific journal of tropical medicine.

[22]  M. Salam,et al.  Prevalence and susceptibility of uropathogens: a recent report from a teaching hospital in Bangladesh , 2015, BMC Research Notes.

[23]  M. Khurshid,et al.  Characteristics and Antibiotic Resistance of Urinary Tract Pathogens Isolated From Punjab, Pakistan , 2015, Jundishapur journal of microbiology.

[24]  S. Hultgren,et al.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options , 2015, Nature Reviews Microbiology.

[25]  M. Findlay,et al.  Urinary Tract Infection in Adults , 2015 .

[26]  H. Khanum,et al.  Prevalence and comparative likelihood of urinary tract infection (UTI) among female out patients in BSMMU , 2013 .

[27]  Chun-Eng Liu,et al.  Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). , 2012, International journal of antimicrobial agents.

[28]  A. Saleh,et al.  Antimicrobial sensitivity pattern of uropathogens in children. , 2010 .

[29]  M. Falagas,et al.  Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. , 2010, International journal of antimicrobial agents.

[30]  S. Puthucheary,et al.  Characterization of Multidrug Resistant ESBL-Producing Escherichia coli Isolates from Hospitals in Malaysia , 2009, Journal of biomedicine & biotechnology.

[31]  J. Winner,et al.  Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus , 2009, Infection and drug resistance.

[32]  T. Johnson.  The problems in scaling adult drug doses to children , 2007, Archives of Disease in Childhood.

[33]  A. Karimi,et al.  Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures. , 2006, Japanese journal of infectious diseases.

[34]  K. Kwon,et al.  Enantioselective pharmacokinetics of Carvedilol in human volunteers , 2004, Archives of pharmacal research.

[35]  I. Morrissey,et al.  A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. , 2003, The Journal of infection.

[36]  A. Movahed,et al.  Use of cardiovascular medications in the elderly. , 2002, International journal of cardiology.

[37]  S. Santen,et al.  Pediatric urinary tract infection. , 2001, Emergency medicine clinics of North America.

[38]  Nithin O. Rajan,et al.  Host pathogenesis in urinary tract infections. , 2001, International journal of antimicrobial agents.

[39]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[40]  W. Stamm.  Measurement of pyuria and its relation to bacteriuria. , 1983, The American journal of medicine.

[41]  A. Klainer.  Manual of Clinical Microbiology , 1970 .

[42]  Gilmore Hr,et al.  Armed Forces Institute of Pathology. , 1968, Oral surgery, oral medicine, and oral pathology.

[43]  A. Saeed,et al.  Genetic and Molecular Mechanisms of Multidrug-Resistance in Uropathogens and Novel Therapeutic Combat , 2021, Biochemistry of Drug Resistance.

[44]  Dr. Sameer Singh Faujdar,et al.  Antibiotic susceptibility profile of uropathogens in rural population of Himachal Pradesh, India: Where We are heading? , 2019, Biomedical and Biotechnology Research Journal (BBRJ).

[45]  M. Bucur,et al.  High resistance rates to 2nd and 3rd generation cephalosporins, ciprofloxacin and gentamicin of the uropathogens isolated in young infants hospitalized with first urinary tract infection , 2017 .

[46]  Hua Yuping,et al.  Resistance of strains producing extended-spectrum β-lactamases and genotype distribution among Escherichia coli in China. , 2012 .

[47]  E. Behzadi,et al.  The Microbial Agents of Urinary Tract Infections at Central Laboratory of Dr. Shariati Hospital, Tehran, IRAN , 2008 .

[48]  S. E. Hui.  District Laboratory Practice in Tropical Countries: Part 2 , 2001 .

[49]  P. Meers,et al.  Boric acid converts urine into an effective bacteriostatic transport medium. , 1989, The Journal of infection.